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Abstract 
Nav1.5 inactivation is necessary for healthy conduction of the cardiac action potential. 
Genetic mutations of Nav1.5 perturb inactivation and cause potentially fatal arrhythmias 
associated with long QT syndrome type 3. The exact structural dynamics of the 
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inactivation complex is unknown. To sense inactivation gate conformational change in 
live mammalian cells, we incorporated the solvatochromic fluorescent non-canonical 
amino acid ANAP into single sites in the Nav1.5 inactivation gate. ANAP was 
incorporated in full-length and C-terminally truncated Nav1.5 channels using mammalian 
cell synthetase-tRNA technology. ANAP-incorporated channels were expressed in 
mammalian cells and they exhibited pathophysiological function. A spectral imaging 
potassium-depolarization assay was designed to detect ANAP emission shifts 
associated with Nav1.5 conformational change. Site-specific intracellular ANAP 
incorporation affords live-cell imaging and detection of Nav1.5 inactivation gate 
conformational change in mammalian cells. 
Statement of significance 
We incorporated a fluorescent non-canonical amino acid ANAP into multiple sites within 
the inactivation gate of human cardiac voltage-gated sodium channels (Nav1.5). We 
developed a fluorescence based spectral method to monitor Nav1.5 conformational 
change in intact mammalian cells. This work compliments the near-atomic level 
structural detail resolved in recent cryo-EM structures of full-length eukaryotic voltage-
gated sodium channels and sets the foundation for measurement of voltage-gated 
sodium channel structural dynamics in mammalian cells. 
Introduction 
Genetic mutation in the voltage-gated sodium channel (VGSC) Nav1.5 can lead to 
multiple cardiac arrhythmia disorders including Brugada Syndrome and long QT 
syndrome type 3 (LQT3), that can both lead to sudden cardiac death. Nav1.5 is a 260 
kDa transmembrane ion channel with four semi-homologous domains, each containing 
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six transmembrane segments (1) (Figure 1a, right). The ~50 amino acid linker between 
domains III and IV (III-IV linker) is known as the inactivation gate. VGSC fast 
inactivation is thought to occur by a hinged-lid mechanism requiring the presence of a 
conserved hydrophobic motif, typically IFM, in the III-IV linker (1). This hydrophobic 
motif may stabilize a channel conformation in which the III-IV linker occludes the 
intracellular mouth of the pore and halts ion conduction (1±5). The IFM motif assumes a 
stable fast inactivated state by docking onto the underside of the pore via hydrophobic 
interactions, mainly with sites on the DIII:S4-S5 linker, DIV:S4-S5 linker, and DIV:S6 (5±
13). The C-terminus (CT) is also important for regulating channel availability and 
inactivation kinetics, demonstrated by functional characterization of LQT3-associated 
mutations in the CT and ion channel chimera experiments (14±19). Furthermore, the 
inactivated state is stabilized by an interaction between the III-IV linker and CT, forming 
an inactivation complex, and this requires the presence of the C-terminal part of helix 6 
in the CT structured region (8, 20±23).  
Structures of truncated regions of eukaryotic VGSCs, such as the III-IV linker, in 
complex with accessory proteins have been reported; however, their functional 
significance is unknown (24, 25). In particular, the eukaryotic III-IV linker bound to 
calcium/Calmodulin (CaM) has been crystallized (24). Also, the crystal structure of the 
eukaryotic Nav1.5 CT domain in complex with fibroblast growth factor homologous 
factor (FHF) and apo-CaM has been resolved (25). Considered together, these results 
raise questions of how the III-IV linker, CT, calcium, and CaM may interact in the 
inactivation complex of full-length eukaryotic channels. One limitation to the studies 
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supporting the significance of a direct III-IV linker CT interaction is the measurement of 
interactions between purified III-IV linker and CT peptides, not in full-length channels.  
A number of cryo-EM structures of full-length eukaryotic VGSCs have been 
published to date: insect NavPaS (26), electric eel Nav1.4 (27), human Nav1.7 (28), 
human Nav1.2 (29), and hybrid NavPaS/human Nav1.7 (30). Interactions between 
voltage sensor domain IV (VSDIV) and the CT were visualized in the full-length hybrid 
channel (insect NavPaS+VSDIV from human NavERXQGWRܤ-scorpion toxin, 
suggesting a possible resting state for the fast-inactivation complex (30). One limitation 
of structural techniques is that there is no membrane potential in a protein crystal. 
Therefore, it is difficult to assign the resolved structure to voltage-dependent functional 
ion channel states. Fluorescence imaging in mammalian cells can be a useful 
complement to cryo-EM studies for connecting structure with function of the Nav1.5 
inactivation complex. Currently, specific fluorescent labeling of the short intracellular 
inactivation gate with minimal perturbation in full-length channels is a technical hurdle 
that must be overcome. 
Options for labeling short intracellular protein linkers are limited. Fluorescent 
proteins are quite large and cysteine labeling is non-specific. Non-canonical amino 
acids (ncAAs) offer an alternative method for incorporating fluorophores at single sites 
in proteins by amber suppression. Amber suppression in mammalian cells requires 
expression of an orthogonal aminoacyl tRNA-synthetase tRNA (aaRS-tRNA) pair 
specific for the ncAA along with the protein of interest containing an amber stop codon 
at the desired incorporation site (31). ANAP (3-((6-acetylnaphthalen-2-yl)amino)-2-
aminopropanoic acid) is one of a number of solvatochromic fluorescent ncAAs whose 
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spectrum red-shifts in increasingly polar environments (32±34) (Figure 1a, left). The 
ANAP aaRS-tRNA pair was evolved in S. cerevisiae from the E. coli leucyl aaRS-tRNA 
pair (32). Since the first demonstration of ANAP incorporation into model proteins in S. 
cerevisiae and mammalian cells, there have been a number of examples using ANAP 
environmental sensitivity to study ion channels in X. laevis oocytes and mammalian 
cells (35±44). 
In recent years, ANAP incorporation has been used increasingly for studying 
protein dynamics in live cells. In 2013, Kalstrup and Blunck demonstrated voltage-clamp 
fluorometry (VCF) of ANAP-incorporated Shaker potassium channels in X. laevis 
oocytes and have published video protocols for reproducing ANAP VCF experiments 
(35, 45). ANAP spectral shifts were used to monitor protein misfolding of luciferase in S. 
cerevisiae (46). In X. laevis oocytes, ANAP has been incorporated into glycine 
receptors, CNGA1 channels, voltage-sensing phosphatases, KCNH channels, and 
ASIC channels (36±41). ANAP incorporated in CNGA1 and KCNH channels was used 
to measure intracellular interactions by transition metal FRET (tmFRET) (36). However, 
there is a need for characterization of ion channel structural dynamics in the mammalian 
cell context. A few studies have answered to that need. Zagotta et al. demonstrated 
tmFRET between ANAP incorporated in TRPV1 channels and the plasma membrane of 
unroofed mammalian cells (42). In CHO cells, ANAP was incorporated into hASIC1a 
and increasing concentrations of the channel toxin mambalgin-1 were detected 
spectrally by a red-shift in ANAP fluorescence (43). ANAP was demonstrated as a 
FRET donor to EGFP in a FP-reporter fusion protein expressed in mammalian cells 
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(47). Recently, Puljung et al. interrogated activation of ATP-sensitive K+ channels in 
unroofed HEK293T cells via FRET between ANAP and fluorescent nucleotides (44).  
We hypothesized that ANAP can be incorporated into the Nav1.5 inactivation 
gate using mammalian cell synthetase-tRNA technology. Once incorporated, ANAP 
would act as a fluorescent reporter of human Nav1.5 conformational change. An ANAP 
spectral assay was developed to address whether ANAP responds to (1) the local 
environment of the inactivation gate when incorporated at different sites (Figure 1b) (2) 
the absence of the distal CT (Figure 1b) and (3) conformational rearrangement elicited 
by a potassium (K+)-depolarization (Figure 1c). 
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Figure 1: Nav1.5 constructs and K+-depolarization assay schematic. (a) Chemical 
structure of ANAP (left), Nav1.5 domain structure (right). (b) Nav1.5(ANAP) constructs 
used in imaging and electrophysiology experiments. Star=ANAP (c) Schematic of K+-
depolarization in cells expressing GFP-Kir4.1 and Nav1.5(ANAP). Net flux of K+ is zero 
at both membrane potentials. 5 mM [K+]ext and 150 [K+]int set the equilibrium potential at 
~-80 mV where Nav channels are expected to be closed. An increase to 150 mM [K+]ext 
sets the equilibrium potential at ~0 mV where a large population of Nav channels is 
expected to be inactivated. 
Materials and methods 
Chemical reagents 
All reagents were purchased commercially. A 1.7 mM stock solution of ANAP (3-((6-
acetylnaphthalen-2-yl)amino)-2-aminopropanoic acid trifluoroacetic acid salt) 
(AsisChem) was made in anhydrous dimethyl sulfoxide (Sigma-Aldrich). A 50 ȝ0 TTX 
(Abcam) solution was made in ddH2O from a 5 mM stock solution. Reagents were 
aliquoted and stored at -20°C. Chemicals for physiological solutions were purchased 
from Sigma-Aldrich and stored at room temperature, unless otherwise noted. Stock 
physiological solutions were stored at 4°C. 
Plasmids, cell lines, and molecular biology 
AnapRS-LeutRNACUA, pcDNA4-EGFP(Y40TAG) ³S6:$1-*)37$*´ and pCMV-
MmPylRS-PylT were gifts from Peter G. Schultz (33, 48). Template plasmids pH2B-
EGFP and pcDNA3-SCN5A hh1c were available in-house. Template plasmid pH2B-
mCherry was a gift from Robert Benezra (Addgene plasmid # 20972). HEK293T cells 
were available in-house. The GFP-Kir4.1 HEK293T cell line was a gift from Christopher 
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Ahern. QuikChange site-directed mutagenesis (Stratagene) and/or Gibson Assembly 
(NEB) ZDVSHUIRUPHGDFFRUGLQJWRWKHPDQXIDFWXUHU¶VLQVWUXFWLRQVZLWKPRGLILFDWLRQVDV
needed.  
Mammalian tissue culture and transfection 
HEK293T cells were grown in a medium containing Minimum Essential Medium (MEM) 
*LEFRRU'XOEHFFR¶V0RGLILHG(DJOH0HGLXP'0(0FRQWDLQLQJJ/JOXFRVH/-
glutamine, and sodium pyruvate (Corning 10-013-CM), 10% Fetal Bovine Serum (FBS), 
1% Penicillin-Streptomycin, and 2 mM GlutaMAX (Gibco) supplement at 37ºC in a 
humidified atmosphere of 5% CO2. Transfections of all cell lines for western blot and 
live-cell imaging (6-well tissue-culture-treated plates for western blot, LabTek 8-well 
chambered coverglass tissue-culture-treated plates for imaging) were performed using 
Xtremegene HP (Roche) or Lipofectamine 2000 (Invitrogen) according to the 
PDQXIDFWXUHU¶VLQVWUXFWLRQV$W\SLFDOLPDJLQJH[SHULPHQWLQYROYHGWUDQVIHFWLRQRIȝJ
WRWDO'1$LQFOXGLQJȝJ1Dv1.5 UHSRUWHUFRQVWUXFWDQGȝJAnapRS-LeutRNACUA 
(1.5:1 target protein to aaRS-tRNA mass ratio). Plasmids were co-transfected with 
UHDJHQWȝ/UHDJHQWWRȝJ'1$LQ2SWL-MEM (Gibco). In +ANAP conditions, ANAP 
was DGGHGWRWKHZHOODWDILQDOFRQFHQWUDWLRQRIȝ0aPLQXWHVSULRUWRDGGLQJ
transfecWLRQUHDFWLRQ7KLVUHFLSHZDVVFDOHGXSWRȝJWRWDO'1$IRUHOHFWURSK\VLRORJ\
experiments, transfected in T25 flasks then split 24 hours later and seeded into 35 mm 
plates. EGFP or EGFP(Y40TAG) was co-transfected as a marker of cells to patch as 
needed (1:1 with Nav1.5(TAG)). GFP-Kir4.1 HEK293T were cultured in DMEM (Gibco), 
10% FBS, 1% Penicillin-Streptomycin, 2 mM GlutaMAX, and Zeocin (Gibco) at 37ºC in 
a humidified atmosphere of 5% CO2. 
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Western blot 
HEK293T cells were seeded at 3x105 cells per well in a 6-well tissue-culture-treated 
SODWHWUDQVIHFWHGDFFRUGLQJWRPDQXIDFWXUHU¶VLQVWUXFWLRQVȝJRI'1$HQFRGLQJ
Nav1.5(TAG)-EGFP, Nav1.5-EGFP, EGFP(Y40TAG), or EGFP was co-transfected with 
ȝJRIAnapRS-LeutRNACUA with Xtremegene (Roche) at a ratio of 3:1 in Opti-MEM 
(Gibco) supplemented with 2 mM GlutaMAX. 10 ȝ0 ANAP was added to the media ~30 
minutes prior to adding transfection reaction. Transfected cells were cultured at 37°C, 
5% CO2 36-48 hours before harvesting and lysis. Prior to lysis, cells were washed once 
with Tris-HCl-buffered saline (TBS), then lysed with Cell Lysis Buffer (Cell Signaling) 
with 1:100 proteasome inhibitor complex on ice for 5 minutes. Lysis buffer contained 
(mM) 20 Tris-HCl (pH 7.5), 150 NaCl, 1 Na2EDTA, 1 EGTA, 1% Triton, 2.5 sodium 
S\URSKRVSKDWHȕ-glycerophosphate, 1 Na3VO4ȝJP/OHXSHSWLQ&HOOVZHUH
scraped and re-suspended in lysis buffer and incubated at 4°C for 30 min utes. Samples 
were centrifuged 10 minutes at 12,000xg then heated (55°C). Samples w ere loaded 
onto a 5% and 10% sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-
PAGE) gel and electrophoresed for 45 minutes at 10 mA/gel, then 90 minutes at 20 
mA/gel. Protein gels were wet-transferred onto polyvinylidene difluoride (PVDF) 
membranes overnight at 4°C (15 V). The membranes were washed bri efly with TBS 
then blocked with 5% w/v skim milk in 1x TBS with Tween 20 (TBS-T) for 30 minutes at 
room temperature. Membranes were then incubated with 1/8000 primary antibody 
(rabbit polyclonal anti-GFP) in (TBS-T) for 1 hour at room temperature. Membranes 
were washed 3x10 minutes at room temperature in TBS-T and incubated with 
secondary antibody (anti-rabbit horseradish peroxidase) 30 minutes at room 
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temperature. Membranes were washed 2x10 minutes at room temperature with TBS-T, 
then 1x10 minutes at room temperature with TBS, and developed using ECL Western 
Blot Detection Reagents (Bio-Rad). Images were taken by exposing light sensitive films 
at 30 seconds, 1 minute, 2 minutes, 3 minutes, and 5 minutes on a developer (Kodak) in 
a dark room. Membranes were stripped, stained with anti-ȕ-tubulin, and imaged as 
above.  
Whole-cell patch-clamp electrophysiology 
Sodium channel electrophysiology 
Electrophysiological recordings of sodium channels expressed in HEK293T were 
carried out in a whole-cell patch clamp configuration using physiological solutions. 
Pipette resistances ranged from 1.5-4 MOhm. The INa internal solution contained (mM) 
50 aspartic acid, 60 CsCl, 5 Na2-ATP, 11 EGTA, 10 HEPES, 1 CaCl2 and 1 MgCl2, with 
pH 7.4 adjusted with CsOH. The INa external solution contained (mM) 130 NaCl, 
2 CaCl2, 5 CsCl, 1.2 MgCl2, 10 HEPES, 5 glucose, with pH 7.4 adjusted with CsOH. 
Whole cell sodium currents were recorded under voltage-clamp conditions. A voltage 
step protocol was used, holding at -100 mV, step depolarization to -20 mV for 200 ms, 
then back to holding. Cells were pulsed at a frequency of 0.1 Hz. SSI voltage protocol 
was as follows: holding at -100 mV or -90 mV, step to the conditioning pulse for 500 ms, 
depolarization to -10 mV for 20 ms, return to holding. Conditioning pulses ranged 
from -130 mV to -20 mV. Late sodium current was measured as TTX-sensitive current 
200 ms after depolarization to -20 mV. Percent late current was measured as the 
average current between 195 mV and 200 mV divided by the peak current. Data was 
collected using an Axopatch 200B amplifier (Axon Instruments) and Digidata 1440A 
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digitizer. Data was recorded with pClamp8, 10, or 10.5 (Molecular Devices). Capacitive 
current and series resistance compensation were carried out using analog techniques 
according to the amplifier manufacturer (Axon Instruments). All measurements were 
obtained at room temperature (25°C). Statistical significance was determined using 
single-IDFWRU$129$ZKHQFRPSDULQJPXOWLSOHJURXSVDQG6WXGHQW¶VW-test assuming 
equal or unequal variances based on a prior F-test of variance. p<0.05 was considered 
statistically significant.   
Potassium channel electrophysiology 
Electrophysiological recordings of GFP-Kir4.1 HEK293T were recorded under voltage-
clamp or current-clamp conditions. Internal solution contained (mM) 150 KCl, 3 MgCl2, 
5 EGTA, 10 HEPES, with pH 7.4 adjusted with KOH. Extracellular solution contained 
(mM) 150 NaCl, 5 KCl, 1 MgCl2, 1.8 CaCl2, 10 HEPES, with pH 7.4 adjusted with 
NaOH. Changes in membrane potential were recorded over time once patch stability 
and Kir4.1 channel expression were confirmed by applying a voltage ramp protocol: 
cells were held at -80 mV and a 500 ms voltage ramp was applied once every 3 
seconds, with voltage increasing linearly from -120 mV to +60 mV, then returned to 
holding. Using pClamp software, a 50x data reduction of recordings was performed for 
data transfer compatibility to Microsoft Excel and Origin (Microcal Software) software. 
All measurements were obtained at room temperature (25°C). Where app ropriate, as in 
comparing reversal potentials between low K+ and high K+, statistical significance was 
GHWHUPLQHGXVLQJ6WXGHQW¶VW-test assuming equal or unequal variances based on a prior 
F-test of variance. p<0.05 was considered statistically significant.   
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Live-cell imaging 
ANAP incorporation and spectral imaging of different sites in Nav1.5 
HEK293T cells were plated at a density of 10,000-20,000 cells per well in LabTek 8-well 
chambered coverglass tissue-culture-treated plates (Nunc, 1.5 borosilicate) 12-24 hours 
before transfection. Transfections were performed as described previously. 
Fluorescence microscopy and spectral imaging of ANAP incorporated at different sites 
in Nav1.5 were performed on a Zeiss LSM 700 confocal microscope (Zeiss). ANAP was 
excited at 405 nm and spectral emission collected from 410-600 nm in 10 nm intensity 
bins (Zeiss). To match the laser intensity as accurately as possible, intensity over 
wavelength was measured for each manually chosen ROI, normalized to ROI area, and 
subtracted by a laser line background area-normalized spectrum measured nearby the 
original ROI which did not contain a visible cell. Laser-subtracted spectra were then 
normalized to the sum of the intensities under the peak. Resulting normalized spectra 
were averaged and errors determined as ±SEM. Peak centroids of each averaged 
spectrum were calculated as: ܲ݁ܽ݇ܥ݁݊ݐݎ݋݅݀ ൌ ݏݑ݉ሺݓܽݒ݈݁݁݊݃ݐ݄ כ ݅݊ݐ݁݊ݏ݅ݐݕሻݏݑ݉ሺ݅݊ݐ݁݊ݏ݅ݐݕሻ  
ANAP spectral imaging with K+-depolarization 
Spectral imaging for the K+-depolarization experiment was performed on a Nikon 
A1RMP confocal microscope with spectral detector (Nikon). Cells were maintained at 
37°C in a 5% CO 2 humidified atmosphere on the microscope with a stage-top incubator 
in live-cell imaging solution (MolecularProbes) or electrophysiological solutions. Live-cell 
imaging solution contained (mM) 140 NaCl, 2.5 KCl, 1.8 CaCl2, 1.0 MgCl2, 20 HEPES, 
with pH 7.4. In K+-depolarization experiments, low K+ external solution contained (mM) 
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150 NaCl, 5 KCl, 1 MgCl2, 1.8 CaCl2, 10 HEPES, with pH 7.4 adjusted with NaOH. High 
K+ external solution contained (mM) 150 KCl, 5 NaCl, 1 MgCl2, 1.8 CaCl2, 10 HEPES, 
with pH 7.4 adjusted with KOH. During imaging, cells were maintained in low K+ 
external solution before buffer exchange to high K+. ANAP was excited at 405 nm and 
spectral emission collected from 402-588 nm in 6 nm intensity bins using the spectral 
detector. The three shortest wavelength bins were affected by a mechanical filter inside 
the spectral detector - a metal finger blocker just after the grating which prevents 
excitation light from entering the photomultiplier arrays. Unmixed ANAP or GFP spectra 
had negligible intensities at the affected wavelengths (Figure S2). Data analysis was 
performed as follows. Composite ANAP and GFP spectra were fitted and unmixed using 
a MATLAB (Mathworks) linear unmixing algorithm built in-house. Three spectral 
components were modeled to fit and unmix experimental spectra: (1) ANAP, (2) 405 nm 
laser line, and (3) GFP. First, the model ANAP spectrum was extracted from ANAP-only 
control HEK293T expressing Nav1.5(Q1475ANAP) and fit as the linear combination of 
two gaussians to obtain a smooth spectrum. Second, a model spectrum of the peak 405 
nm laser light background was determined by measuring spectra from ROIs drawn 
where there were no visible cells. Third, the GFP model spectrum was extracted from 
GFP-only control GFP-Kir4.1 co-transfected with Nav1.5(Q1475TAG) and AnapRS-
LeutRNACUA in the absence of ANAP. The GFP model spectrum was laser-subtracted 
using the model spectrum of the laser light background determined in (2). The best GFP 
fit was a linear combination of two log-normal distributions(49). Once the model spectra 
were obtained, least squares regression was performed over the entire wavelength 
range (402-588 nm) to fit how bright each of the peaks need to be to explain the 
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observed spectrum at each wavelength. To account for ANAP shifts, the least squares 
fit was calculated at one particular wavelength of ANAP and the residual was recorded. 
The code iterated 20 nm to the left and right of the peak in 1 nm steps, down-sampled 
to the instrument resolution, until residuals were minimized, resulting in the best fit 
overall.  
Results 
Fluorescent ncAA ANAP was incorporated into the Nav1.5 inactivation gate in 
mammalian cells. 
Can fluorescent ncAA ANAP be incorporated into the human Nav1.5 inactivation gate in 
mammalian cells? In proof-of-principle ANAP incorporation experiments, EGFP or 
mCherry was fused to the human Nav1.5 CT as a reporter of full-length channel 
expression (Figure 1b, construct 2). ANAP-dependent expression of full-length Nav1.5-
EGFP (~275 kDa) was measured by western blot for four sites: Q1475TAG, F1485TAG, 
E1488TAG, and E1489TAG (Figure 2a). In the presence of ANAP, a band was 
observed above 200 kDa, corresponding to the more intense positive control band of 
the same size, representing full-length Nav1.5-EGFP. The positive control for ncAA 
incorporation was to incorporate ANAP into EGFP(Y40TAG). ANAP-dependent full-
length expression of EGFP (~27 kDa) was observed at ~50 kDa, corresponding to the 
band from cells expressing wild-type EGFP (Figure 2a). In both cases, no band was 
observed in the absence of ANAP. ȕ-tubulin normalized band intensities in the ncAA 
incorporation conditions were 16% for Q1475ANAP, 7% for F1485ANAP, 11% for 
E1488ANAP, and 31% for E1489ANAP, of that in the wild-type condition. These results 
demonstrate ANAP-dependent expression of full-length sodium channel reporter protein 
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in mammalian cells and emphasize the high variability in ncAA-incorporation efficiency 
depending on target incorporation site. 
 Nav1.5 was tested for permissibility to ANAP incorporation. A site in DIII:S6 
Q1475TAG was chosen initially for ANAP incorporation because we hypothesized that 
this site being close to the membrane-cytosol interface would elicit detectable spectral 
shifts representing changes in hydrophobicity in the K+-depolarization assay (26, 30). 
HEK293T cells expressing Nav1.5(Q1475ANAP)-mCherry were imaged by confocal 
microscopy (Figure 2b). In the +ANAP condition, ANAP and mCherry fluorescence was 
observed at the plasma membrane and localized to intracellular compartments (Figure 
2b, columns 1,2). This was expected due to the DEVHQFHRIȕVXEXQLWRYHUH[SUHVVLRQ, 
which can cause defective plasma membrane trafficking (50). ANAP fluorescence 
intensity correlated (R2=0.6) with mCherry fluorescence intensity in the 
Nav1.5(Q1475ANAP)-mCherry condition (Figure 2c, right). As a negative control 
representing background ANAP fluorescence, wild-type Nav1.5-mCherry and AnapRS-
LeutRNACUA were co-expUHVVHGLQ+(.7ȝ0ANAP (Figure 2b, column 3). 
Bright mCherry fluorescence and dim ANAP fluorescence was observed, but ANAP 
signal was significantly decreased compared to the Nav1.5(Q1475ANAP)-mCherry 
condition (Figure 2c, left).   
As a negative control to evaluate ANAP-independent expression of the reporter 
protein, Nav1.5(Q1475TAG)-mCherry was expressed in the presence of AnapRS-
LeutRNACUA in HEK293T grown without ANAP (Figure 2b, column 4). Cell auto-
fluorescence and dim mCherry signal were observed, but both signals were decreased 
compared to the Nav1.5(Q1475ANAP)-mCherry condition. Together, these data 
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demonstrated ANAP-dependent full-length Nav1.5 expression, suggesting that ANAP 
can be incorporated into the inactivation gate. Furthermore, ANAP fluorescence signal 
can be visualized and distinguished from background by routine confocal imaging.  
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Figure 2: Full-length Nav1.5 expression depends on presence of ANAP and its 
synthetase-tRNA pair. (a) Western blot of Nav1.5(Q1475TAG)-EGFP and 
(*)3<7$*JURZQLQ+(.7ȝ0$1$3SUREHGZLWKUDEELWS$E-GFP. All 
conditions were co-transfected with AnapRS-tRNALeuCUA. (Left) Nav1.5-EGFP, 5% 
SDS-PAGE, 5 min exposure. (Right) EGFP, 10% SDS-PAGE, 1 min exposure. Each 
image in its entirety was adjusted for contrast and brightness enhancement. Full-length 
EGFP is ~27 kDa and was observed ~50 kDa in this blot. Full-length Nav1.5-EGFP is 
~275 kDa and was observed above 200 kDa in this blot. (b) Fluorescence imaging of 
HEK293T expressing Nav1.5(Q1475ANAP)-mCherry (columns 1, 2), Nav1.5-
P&KHUU\ȝ0$1$3EDFNJURXQG$1$3FRlumn 3), or Nav1.5(Q1475TAG)-mCherry 
in the absence of ANAP (transfected cells no ANAP, column 4). ANAP (ex405, 
em445/50 nm) and mCherry (ex555, em647/70 nm) fluorescence were imaged. Overlay 
image includes ANAP (white), mCherry (red), and brightfield channels. All except 
brightfield images were equally adjusted in their entirety for contrast enhancement. (c) 
Quantification of the 20x images in (b). (Left) ANAP mean fluorescence intensity (MFI) 
was significantly increased when the target codon for incorporation was present. 
****p<0.0001, two-tailed unpaired t-WHVWZLWK:HOFK¶VFRUUHFWLRQ5LJKWP&KHUU\0),
plotted as a function of ANAP MFI. 
Electrophysiology of ANAP incorporated full-OHQJWKDQGǻ&7WUXQFDWHGNav1.5 in cells.  
We asked whether functional channel expression at the plasma membrane depended 
on the presence of ANAP and its incorporation machinery. Furthermore, because the 
Nav1.5 inactivated state is stabilized by helix 6 in the CT structured region, we sought to 
measure the effect of truncating helix 6 and the entire distal CT on Nav1.5(ANAP) 
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function (8, 20±23). We used the previously characterized truncation mutation 
67*$ǻ&7 (8). Patch-clamp electrophysiology was used to characterize 
Nav1.5(Q1475ANAP), Nav1.5(ǻ&7), or Nav1.5(Q1475ANAP/ǻ&7) co-expressed with 
EGFP(Y40ANAP) in HEK293T cells. EGFP(Y40ANAP) was a marker of cells able to 
carry out ncAA incorporation. In +ANAP conditions, TTX-sensitive sodium currents were 
observed in EGFP-positive cells (Figure 3a), although peak current density was 
significantly decreased compared to wild-type channels (Figure 3b). Decreased peak 
current density of ANAP incorporated channels could be due to defects in channel 
trafficking to the plasma membrane, lower channel expression, or a decrease in single 
channel conductance. Notably, small or no currents were observed in cells expressing 
all components for ANAP incorporation but grown in the absence of ANAP (Figure 
3a,b). This suggests that sodium currents observed in the presence of ANAP are 
dependent on ANAP incorporation and represent full-length Nav1.5(Q1475ANAP) or 
truncated Nav1.5(Q1475ANAP/ǻ&7) channels.  
Next, the inactivation properties of Nav1.5(Q1475ANAP) and 
Nav1.5(Q1475ANAP/ǻ&7) channels were characterized. Macroscopically, currents 
resembled Nav channels, with rapid opening and inactivation in response to a step 
change in membrane depolarization. There was lengthened time to half-complete 
inactivation (t1/2) and increased late current (INa,L) in cells expressing 
Nav1.5(Q1475ANAP), Nav1.5(ǻ&7), or Nav1.5(Q1475ANAP/ǻ&7) (Figure 3d,e). The 
steady-state inactivation (SSI) curve of Nav1.5(Q1475ANAP), a measure of voltage-
dependent transitions between the closed and closed-inactivated states, was shifted 
towards more depolarized potentials relative to wild-type, suggesting destabilized 
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inactivation and thus, an increase in availability of these channels to open and inactivate 
(Figure 3c). The SSI curve of Nav1.5(ǻ&7) was shifted towards hyperpolarized 
potentials relative to wild-type (Figure 3c). Incorporation of ANAP at Q1475 resulted in a 
depolarizing shift of the SSI curve relative to wild-type, and the combination of 
Q1475ANAP/ǻ&7FRXQWHUDFWHGWKHGHSRODUL]LQJVKLIW (Figure 3c). Together, 
electrophysiological data suggest that ANAP can be incorporated at Q1475 in the 
Nav1.5 inactivation gate to make functional channels. While channel function is different 
from wild-type, it is within pathophysiological range (51±53). 
 
Figure 3: Electrophysiology of ANAP incorporated full-OHQJWKDQGǻ&7WUXQFDWHG
Nav1.5 in HEK293T cells. (a) Representative TTX-sensitive capacitance-normalized 
current traces of wild-type Nav1.5, Navǻ&71Dv1.5(Q1475ANAP), or 
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Nav4$1$3ǻ&7H[SUHVVHGLQ+(.7$OOFRQGLWLRQVZHUHFR-transfected 
with AnapRS-LeutRNACUA. Inset is the voltage protocol. (b) Average peak current 
density (pA/pF) of all conditions. Numbers above bars are the number of cells *(left to 
right) two-tailed p=8.5x10-5, 1.7x10-5, 0.02, 5.6x10-66WXGHQW¶VW-test. Peak currents and 
cell capacitances are in Figure SF6WHDG\VWDWHLQDFWLYDWLRQRIDOOFRQVWUXFWVȝ0
ANAP. Inset is the voltage protocol. Numbers in legend refer to number of cells. V1/2: 
WT -64.6±0.4 mV, Q1475ANAP -P9ǻ&7-79.2±0.4 mV, 
4$1$3ǻ&7-59.7±0.6 mV (d) Time to half-complete inactivation (t1/2, ms) of all 
constructs. Numbers above bars are the number of cells. *(left to right) two-tailed 
S 6WXGHQW¶VW-test. (e) High-gain TTX-sensitive capacitance-normalized 
traces of all constructs using same voltage protocol as in (a). Arrow indicates late 
sodium current (INa,L). INa,L (% peak current, late current density): WT (0.3%, 1 pA/pF), 
4$1$3S$S)ǻ&7S$S)4$1$3ǻ&7
pA/pF). 
Spectral imaging of Nav1.5ANAP enables sensing of hydrophobicity in intracellular 
environment. 
We then asked if ANAP environmentally sensitive fluorescence could be measured in 
mammalian cells. Spectral imaging was used to measure ANAP fluorescence emission 
and spectral shifts in mammalian cells. Four different sites were tested for ANAP 
incorporation into Nav1.5(TAG) expressed in HEK293T (Figure 4a). ANAP spectra 
associated with each site demonstrated unique emission peaks: Nav1.5(Q1475ANAP) 
(centroid 480 nm), Nav1.5(F1485ANAP) (centroid 484 nm), Nav1.5(E1488ANAP) 
(centroid 482 nm), and Nav1.5(E1489ANAP) (centroid 483 nm) (Figure 4b). Background 
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ANAP in the presence of wild-type Nav1.5 was red-shifted with a peak centroid of 489 
nm. The fluorescence ratio F456nm/F499nm was significantly different between sites, 
with Nav1.5(Q1475ANAP) being the most blue-shifted (high F456nm/F499nm) and 
F1485ANAP (low F456nm/F499nm) the most red-shifted (Figure 4c). As a test for the 
reliability of observations using spectral imaging and separation of signal spectrum from 
laser light, results were compared between biological replicates and the resulting shifts 
were not significantly different (Figure S3). A blue-shift represents a more hydrophobic 
environment. Thus, Nav1.5(Q1475ANAP) was situated in the most hydrophobic 
environment; the location of this site at the end of DIII-S6 lends itself to an expectation 
of a more hydrophobic environment (26, 30). Nav1.5(F1485ANAP) was in a relatively 
less hydrophobic environment. Background ANAP was red-shifted and therefore was 
situated in the least hydrophobic environment. These data represent sensing of 
hydrophobicity in the local environment of ANAP incorporated in the inactivation gate of 
full-length Nav1.5 expressed in mammalian cells. 
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Figure 4: ANAP spectral imaging afforded detection of hydrophobicity in 
intracellular environment. (a) Schematic of the inactivation gate depicting the location 
of the four sites tested, Q1475, F1485, E1488, and E1489. F1485 is a part of the IFM 
motif, known as the inactivation particle. Approximate location of the membrane is 
depicted by the dashed line. Adapted from PDB structure 5XSY (27) (b) ANAP spectra, 
laser line background subtracted and normalized to the sum of intensities under each 
peak. ANAP at each of the four sites is compared with background ANAP control (wild-
type Navȝ0$1$3EODFN'DVKHGER[VKRZVLQVHWwhere spectra are zoomed 
in on the peak. n=12 cells for each condition, representative of 2 experiments, error bars 
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are ±SEM. (c) Fluorescence ratio F456nm/F499nm measured for each condition, error bars 
are ±SEM. S$129$ZLWK7XNH\¶VPXOWLSOH comparisons test.  
A spectral imaging assay allows measurement of Nav1.5 conformational change in 
mammalian cells. 
A spectral imaging assay was developed to detect ANAP fluorescence changes 
correlated with inactivated states of Nav1.5 channels expressed in mammalian cells. 
Q1475ANAP was chosen as a proof-of-principle for the spectral imaging assay because 
we hypothesized that this site being close to the membrane-cytosol interface would elicit 
detectable spectral shifts representing changes in hydrophobicity. We explored the 
HIIHFWRIWKHǻ&7mutation on ANAP spectra with K+-depolarization since truncation of 
the distal CT destabilizes the inactivated state, causing a marked shift in the voltage-
dependence of SSI (8, 23). We hypothesized that these changes would cause a 
conformational change that ANAP fluorescence shifting would reflect. 
Spectral imaging of ANAP was combined with K+-depolarization such that 
sodium channel state could be changed from closed to inactivated during imaging. In 
order to control membrane potential without voltage clamp we used Kir4.1, which is 
sensitive to [K+]ext and thus enables (1) establishment of the initial RMP at a 
hyperpolarized potential such that VGSCs will be closed and available, and (2) steady 
state depolarization of the RMP upon addition of increased [K+]ext to drive the transition 
between VGSC closed and inactivated states (54±56). Based on SSI curves of 
Nav1.5(Q1475ANAP) (Figure 3c), when the resting membrane potential (RMP) is set to 
a hyperpolarized potential, channels at the membrane are expected to be in the resting, 
closed-available state (Figure 1c). With a depolarization of the membrane, channels are 
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expected to open and quickly inactivate, or undergo transitions to slow-inactivated 
and/or closed-inactivated states, resulting in a mixed population of inactivated channels 
at steady state (Figure 1c) (57).  
A stable HEK293T cell line expressing GFP-Kir4.1 was obtained to control RMP 
during spectral imaging experiments. A representative current-clamp trace 
demonstrates that transition from 5 mM [K+]ext (low K+) to 150 mM [K+]ext (high K+) 
changed the membrane potential from -76 mV to -5 mV (Figure 5a, left). The reversal 
potential of these cells was shifted from approximately -80 mV to 0 mV with increased 
[K+]ext (Figure 5a, right). Expression of Nav1.5(ANAP) in the GFP-Kir4.1 HEK293T cell 
line resulted in composite ANAP-GFP spectra that were unmixed and fitted to measure 
shifting ANAP peaks (Figure S4). Dual-fluorescent ANAP- and GFP-positive cells were 
manually chosen for spectral analysis. The spectrum from each cell was individually 
unmixed from laser line background and GFP.  
To enhance the reliability of unmixing of spectra and to isolate cells expressing 
GFP-Kir4.1, selection criteria were introduced in post-processing. First, as a goodness-
of-fit measure, the summed absolute residuals (SAR) after the fit were compared to the 
total intensity (TI) in the spectrum. A threshold in the SAR-TI ratio was identified 
empirically as one at which the standard deviation of the shift in the fitted ANAP peak 
rapidly started to increase (Figure S6a). Cells with SAR/TI<0.04 were excluded from 
further processing. Second, spectra from reliably expressing GFP-Kir4.1 cells were 
selected by comparing the amplitude of the fitted GFP peak (AGFP) to the SAR. The 
AGFP-SAR ratio below which the GFP signal was comparable to the residuals was 
deemed the threshold for accepting a positive identification of GFP-Kir4.1 expression, at 
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AGFP/SAR>0.3 (Figure S6b, c). Since certain spectra showed high expression of GFP 
with relatively low ANAP signals, a further criterion was introduced to ensure that a well 
resolved ANAP signal existed - ANAP amplitude (AA) to SAR ratio above AA/SAR>1.  
Spectra of Nav1.5(Q1475ANAP) show ANAP fluorescence shifts depending on 
[K+]ext and presence of the distal CT (Figure 5b). GFP peaks were unaltered in the same 
experiments (Figure S5). K+-depolarization caused a small but significant red-shift in the 
ANAP spectra of full-length Nav1.5(Q1475ANAP) (Figure 5b, left). Notably, K+-
depolarization caused no change in ANAP spectra of ǻ&7channels (Figure 5b, center). 
The red-shift was not observed in cells expressing Nav1.5(Q1475ANAP) but failing the 
GFP threshold test, validating that the spectral shift depends on the presence of GFP-
Kir1.4 and thus on the membrane potential (Figure 5b, right). These data suggest the 
distal CT plays a role in mediating inactivation gate conformational change associated 
with inactivation. A general ANAP spectral imaging K+-depolarization assay for probing 
Nav1.5 conformational change in channels expressed in mammalian cells has been 
established. 
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Figure 5: A K+-depolarization ANAP spectral imaging assay of Nav1.5 
conformational change. (a) Establishment of K+-depolarization to control resting 
membrane potential (RMP). (left) Representative current-clamp trace of GFP-Kir4.1 
HEK293T stable cells. Range in Vm is -80 mV to 0 mV with increasing [K+]ext  from 5 mM 
to 150 mM. (right) Reversal potential of GFP-Kir4.1 cells can be changed from -80 mV in 
low K+ (5 mM [K+]ext) to ~0 mV in High K+ (150 mM [K+]ext). Inset is the voltage protocol. 
(b) Spectra of full-length Nav1.5(Q1475ANAP) (left) and Nav1.5(Q1475$1$3ǻ&7
(middle) in cells expressing GFP-Kir4.1 and Nav1.5(Q1475ANAP) in cells with no GFP-
Kir4.1 (AGFP/SAR<0.3) (right), at low K+ and high K+. Q1475ANAP low K+, n=36 cells, 
Q1475ANAP high K+Q FHOOV4$1$3ǻ&7ORZ.+, n=21 cells, 
4$1$3ǻ&7KLJK.+, n=19 cells, Q1475ANAP no GFP-Kir4.1 low K+, n=18 cells, 
Q1475ANAP no GFP-Kir4.1 high K+, n=16 cells. Error bars are ± standard error of the 
average relative brightness of the channel. Spectra are zoomed in on the peak. *p 
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values (left to right) full-length Nav1.5(Q1475ANAP): p=0.02, 0.02, 0.0009, 0.008, 0.04, 
6WXGHQW¶VW-test. 
Discussion 
Site-specific incorporation of the environmentally sensitive fluorescent ncAA ANAP into 
the Nav1.5 intracellular inactivation gate was achieved using synthetase-tRNA 
technology in mammalian cells. ANAP incorporated into a fluorescent reporter 
Nav1.5(Q1475TAG)-mCherry was imaged, demonstrating ANAP and mCherry 
fluorescence localization at the cell membrane and intracellular compartments (Figure 
2b). In Nav1.5(Q1475ANAP)-mCherry imaging experiments, ANAP background 
fluorescence was observed and may result from incomplete washout of unincorporated 
ANAP. Also, ANAP incorporation could potentially occur at non-target amber codons. In 
the absence of ANAP, auto-fluorescence was observed in the ANAP channel and dim 
mCherry fluorescence was observed in the mCherry channel. Collected ANAP emission 
was in the blue visible light spectrum where auto-fluorescence is expected due to 
natural amino acids and other biomolecules such as NADH and NADPH (58, 59). 
mCherry background fluorescence may result from ANAP-independent readthrough of 
the target stop codon or initiation of mCherry expression. It is notable that auto-
fluorescence and background mCherry fluorescence signals were negligible compared 
to fluorescence signals when ANAP and its target site of incorporation were present 
(Figure 2b,c). 
Patch-clamp electrophysiology revealed ncAA-dependent sodium currents in 
cells expressing Nav1.5(Q1475ANAP) or Nav1.5(Q1475ANAP/ǻ&7), whereas little to no 
sodium currents were observed in the absence of ANAP (Figure 3), further 
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corroborating successful incorporation of the fluorescent ncAA ANAP into functional 
channels. Electrophysiological characterization of Nav1.5(Q1475ANAP) and 
Nav1.5(Q1475ANAP/ǻ&7) demonstrated decreased peak current density, and for ANAP 
incorporation, imaging data suggest a considerable population of fluorescent channels 
was localized in intracellular compartments (Figure 2b). Decreased peak current density 
could represent defective channel trafficking, lower channel expression, or decreased 
single-channel conductance. Single-channel functional characterization was not 
performed in this work and would clarify the possible effect of each ncAA on single-
channel conductance. However, defective trafficking and lower channel expression are 
expected to be primary causes of decreased peak current density. Lower expression of 
ncAA-incorporated channels is expected due to competition with endogenous release 
factors at the site of incorporation (31). Defects in channel trafficking to the membrane 
are known to ocFXULQWKHDEVHQFHRIȕVXEXQLWRYHUH[SUHVVLRQ, and could be 
compounded by an unknown trafficking effect associated with ncAA-incorporated 
channels (50); co-H[SUHVVLRQZLWKȕVXEXQLWZRXOGOLNHO\LPSURYH1Dv1.5(ANAP) 
expression at the membrane and should be employed in future work. Single amino acid 
mutation of this region is sufficient to alter channel function, evidenced by LQT3 
mutations and the work herein (51). While channel function was altered by ANAP 
incorporation into the inactivation gate, properties remained within pathophysiological 
range, and most closely mimicked those of a characterized LQT3 mutant channel 
F1473C (51). The method developed herein facilitates experiments with LQT3 mutant 
channels that could elucidate Nav1.5 structural dynamics in a pathological context. 
29 
 
Spectral imaging was used to measure ANAP emission in Nav1.5 in live 
mammalian cells. Unique ANAP spectra were observed with ANAP incorporated at four 
different sites in Nav1.5 Q1475, F1485, E1488 and E1489, and spectra were red-shifted 
in the absence of a target stop codon for incorporation, indicating sensing of 
hydrophobicity in local environment of the inactivation gate (Figure 4). It should be 
noted that fluorescence from background ANAP (unincorporated or in a channel not in 
the membrane) cannot be separated from target-incorporated ANAP fluorescence at 
this point. Therefore, the interpretation of absolute shifts in ANAP spectra cannot be 
clear, and we restrict our conclusions to relative shifts. While imaging data suggest a 
considerable portion of ANAP was localized to intracellular compartments, 
electrophysiology data showed that a detectable population of functional channels 
reached the plasma membrane in an ANAP-dependent fashion. Spectra from the 
membrane only vs. membrane and cytosol exhibited no observable difference in our 
setup, so spectra from the whole cell were analyzed to maximize ANAP signal 
(Figure S2). 
This study provided proof-of-principle evidence of a K+-depolarization ANAP 
spectral imaging assay which was developed to detect effects on conformational 
rearrangement of the inactivation gate in response to a change in membrane potential 
without patch-clamp. For this purpose, experiments were performed to test the specific 
HIIHFWVRIWKHǻ&7DQGFKDQQel state. K+-depolarization allowed sodium channel state at 
the plasma membrane to be changed from closed to a mixture of open- and closed-
inactivated states in a steady-state fashion during spectral imaging (Figure 1c). The 
timescale of the K+-depolarization assay was significantly longer than that of fast 
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inactivation, therefore it is more likely the assay detected intermediate- or slow-
inactivated states (57). When channels are inactivated and the CT is intact, a change in 
the position of DIII-S6 (relative to resting) may increase hydrophobicity in the 
environment of Q1475ANAP leading to a subtle red-shift in the ANAP spectra (Figure 
5b, left). The change in position of DIII-S6 may lead to a change in the affinity of the III-
IV linker-pore complex, destabilizing the inactivation gate. ANAP spectra were unshifted 
in ǻ&7channels with K-depolarization, which may suggest that the absence of the 
distal CT can prevent entry into inactivated states, although it is possible there is a 
conformational change that is undetectable with the current experimental setup.  
Simultaneous electrophysiology and fluorescence measurements in mammalian 
cells would definitively link ANAP spectral shifts to Nav1.5 inactivation dynamics and 
characterization of all the ANAP-incorporated sites in the K+-depolarization assay would 
further validate the method. The ability to label the inactivation gate and measure 
fluorescence spectral shifts associated with VGSC conformational change is an 
invaluable method setting the foundation for such future studies. Notably, the presented 
method could be used to screen environmentally sensitive positions in Nav1.5 or other 
channels in mammalian cells as a first-pass substitute for patch-clamp fluorometry. 
Conclusion 
ANAP was incorporated into the Nav1.5 inactivation gate in mammalian cells, resulting 
channel function was modestly perturbed, and ANAP fluorescence was sensitive to the 
intracellular environment, as well as to channel state. Site-specific fluorescent 
incorporation of ANAP combined with K+-depolarization enabled direct monitoring of 
Nav1.5 inactivation gate conformational rearrangement in channels expressed in live 
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mammalian cells. The K+-depolarization ANAP spectral assay is a general assay for 
studying conformational dynamics of the Nav1.5 inactivation gate and regulators thereof 
in mammalian cells. It could provide insight on outstanding questions of VGSC 
regulation, for instance, by calcium, kinases (PKA, CAMKII, Fyn), and growth factors 
(FHF) (60). Furthermore, the development of such an assay can similarly be applied to 
other ion channels and membrane proteins to gain site-specific knowledge of their 
conformational dynamics in mammalian cells. 
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